Literature DB >> 15195659

Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.

Helena Modin, Wiveka Olsson, Jan Hillert, Thomas Masterman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15195659      PMCID： PMC1182099          DOI： 10.1086/420977

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  6 in total

1.  HLA-DR15 is associated with lower age at onset in multiple sclerosis.

Authors:  T Masterman; A Ligers; T Olsson; M Andersson; O Olerup; J Hillert
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

Review 3.  Genetics of demyelinating diseases.

Authors:  J R Oksenberg; E Seboun; S L Hauser
Journal:  Brain Pathol       Date:  1996-07       Impact factor: 6.508

Review 4.  HLA association with autoimmune disease: a failure to protect?

Authors:  E Zanelli; F C Breedveld; R R de Vries
Journal:  Rheumatology (Oxford)       Date:  2000-10       Impact factor: 7.580

5.  HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Authors:  L F Barcellos; J R Oksenberg; A B Begovich; E R Martin; S Schmidt; E Vittinghoff; D S Goodin; D Pelletier; R R Lincoln; P Bucher; A Swerdlin; M A Pericak-Vance; J L Haines; S L Hauser
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

6.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422
  6 in total
  8 in total

Review 1.  The immunogenetics of multiple sclerosis: A comprehensive review.

Authors:  Jill A Hollenbach; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2015-07-02       Impact factor: 7.094

Review 2.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

3.  HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.

Authors:  Eleonora Cocco; Claudia Sardu; Enrico Pieroni; Maria Valentini; Raffaele Murru; Gianna Costa; Stefania Tranquilli; Jessica Frau; Giancarlo Coghe; Nicola Carboni; Matteo Floris; Paolo Contu; Maria Giovanna Marrosu
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

4.  High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Authors:  Steven J Mack; Julia Udell; Franziska Cohen; Kazutoyo Osoegawa; Sharon K Hawbecker; David A Noonan; Martha B Ladner; Damian Goodridge; Elizabeth A Trachtenberg; Jorge R Oksenberg; Henry A Erlich
Journal:  Genes Immun       Date:  2018-01-08       Impact factor: 2.676

5.  Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.

Authors:  Roberta Pastorino; Cristina Menni; Monserrata Barca; Luisa Foco; Valeria Saddi; Giovanna Gazzaniga; Raffaela Ferrai; Luca Mascaretti; Frank Dudbridge; Carlo Berzuini; Salvatore Bruno Murgia; Maria Luisa Piras; Anna Ticca; Pier Paolo Bitti; Luisa Bernardinelli
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

6.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

7.  The inheritance of resistance alleles in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Andrew P Morris; David A Dyment; Blanca M Herrera; Gabriele C DeLuca; Matthew R Lincoln; Sarah M Orton; Michael J Chao; A Dessa Sadovnick; George C Ebers
Journal:  PLoS Genet       Date:  2007-07-20       Impact factor: 5.917

8.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.